C&Y Pharmaceutical(SZ:300254) Zheng Quan Zhi Xing·2025-07-22 16:16Group 1 - The company is named Shanxi C&Y Pharmaceutical Group Co., Ltd, established as a joint-stock company in accordance with the Company Law of the People's Republic of China [1][2] - The registered capital of the company is RMB 248,318,563, and the actual capital is also RMB 248,318,563 [2] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on August 19, 2011, after an initial public offering of 33.8 million shares [1][2] Group 2 - The company's business purpose is to care for life, stemming from professionalism [3] - The company is engaged in the production of pharmaceuticals and internet information services related to pharmaceuticals [3][4] Group 3 - The company has a total of 248,318,563 shares, all of which are ordinary shares [5] - The company cannot provide financial assistance for others to acquire its shares, except for employee stock ownership plans [5][6] Group 4 - The company can increase its capital through various methods, including issuing shares to unspecified objects and reducing registered capital as per legal requirements [6][10] - The company is allowed to repurchase its shares under specific circumstances, such as reducing registered capital or for employee stock ownership plans [10][11] Group 5 - Shareholders have rights to dividends and other benefits proportional to their shareholdings, and they can participate in shareholder meetings and exercise voting rights [15][35] - The company must maintain a shareholder register based on the records provided by the securities registration and settlement institution [34] Group 6 - The company must hold an annual general meeting within six months after the end of the previous fiscal year [52] - The company can hold temporary shareholder meetings under certain conditions, such as when the number of directors is insufficient or when requested by shareholders holding more than 10% of shares [53][58]